ArticleNature communications2026

Tumor-targeted IL-10 synergizes with IL-2 to enhance antitumor immunity while minimizing immune-related adverse events.

Zhichen Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.